Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Recruiting	Not stated	2025-06-19		NCT07028970

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nanjing IASO Biotechnology Co., Ltd.	14

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Henan Cancer Hospital Affilated Cancer Hospital of Zhengzhou University	Zhengzhou	China	2
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences	Tianjin	China	2
Peking University First Hospital	Beijing	China	72
People's Hospital of Peking Universit	Beijing	China	1
Tianjin Medical University General Hospital	Tianjin	China	28
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	11